_________ false

ליניאג' סל תרפיוטיקס אינק	2 379
.LINEAGE CELL THERAPEUTICS, INC
Corporation no: 876343	10834

	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	11/03/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-02-016022	Time of broadcast: 10:21 10:21

Report of Periodic or Interim Report

Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Full_Year_2024_Financial_Results_isa.pdf

Link to filing on foreign stock exchange (optional): _________

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market: -1	Date of revision of form structure: 06/08/2024
Address: HARBOR BAY PARKWAY 1301 , ALAMEDA 94502   CALIFORNIA , U.S.A Tel: 5105213390 , Fax: 5105213389
E-mail address: info@biotimeinc.com   Company site: biotimeinc.com
Previous names of reporting entity: .BIOTIME, INC
Name of the Signatory: Gerzi SHNEOR Ilan Position of Signatory in the reporting corporation: Legal Adviser Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ
Address: Derech Menachem Begin 121 , Tel Aviv 6701203 Telephone: 03-3039000 Facsimile: E-mail: igerzi@pearlcohen.com 1
U.S.A